26.07.2013 • NewsDede WillamsDow ChemicalMonotez

Former Dow Business Styron to be sold to Ravago

Styron Europe, part of the former Dow Chemical styrenics activities spun off in 2010 and subsequently sold to private equity, is selling its European expandable polystyrene (EPS) business to RP Compounds, subsidiary of privately owned Belgian compounder and distributor Ravago.

The agreement foresees a Ravago acquiring Styron's 70,000 t/y EPS plant at Schkopau, Germany, as well as related intellectual property and the Sconapor brand name.

The sale of the business built up by Dow in the mid-1990s following its acquisition of the recently privatized East German assets of Buna-SOW-Leuna is in line with Styron's strategic goal of refining its portfolio, said company president and CEO Chris Pappas. "The EPS business will be a stronger fit for Ravago as they are strategically committed to growing in this area," Pappas said. 

The expertise of the Styron EPS team and the high level of the factory setup will further strengthen Ravago's manufacturing platform and technologies," said CEO Theo Roussis, noting that "the customer portfolio is very complimentary." The Belgian company had been seeking to pick up additional EPS assets following the 2012 acquisition of Greek producer Monotez.

Styron's private equity owner Bain Capital recently shelved plans for an initial public offering for an undisclosed volume of shares and rebrand the company as Trinseo, a name already being used for some segments of the business. Bain had initially hoped to raise $400 through the offering. 

Interview

Innovation at the Intersection of AI
Digital Potential in Key Business Areas

Innovation at the Intersection of AI

Stefan Guertzgen spoke with John Banovetz, Chief Technology Officer at 3M, about the role of digital transformation in achieving the company's objectives.

Whitepaper

Cannabis Extraction — Temperature Control Systems in Action

Cannabis Extraction — Temperature Control Systems in Action

Cannabis is a crop that has been cultivated for thousands of years and contains many pharmacologically active substances.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.